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Recently the 3D structure of the Osaka mutant form (E221) of Amyloid-β1-40 has
been determined. We here compare the NMR chemical-shift with the published shifts
of a brain-seeded form of wild-type Aβ and suggest that the determined mutant fold is
accessible to the wild-type protein as well, with small conformational adaptations which
accommodate the E22 residue missing in the Osaka mutant. In addition, we illustrate
how other mutants could also conform to this model. The stabilization of the N-terminal
part of the protein via an intermolecular salt bridge to Lys28 may represent a common
structural motif for the mutants which are related to early-onset Alzheimer disease. This
feature might connect to the observed increased toxicity of the mutant forms compared
to wild-type Aβ1-40, where the salt bridge involving Lys28 is intramolecular.
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Introduction
Amyloid-β (Aβ) in its different conformations and aggregation states is a central player in the
amyloid-cascade hypothesis for Alzheimer’s disease (AD) (Hardy and Higgins, 1992). Brain-
derived or synthetic aggregates were shown to propagate between cells when injected into
transgenic mice (Kane et al., 2000; Eisele et al., 2010). It is not established whether the Aβ fibrils
or smaller oligomers, or both, are the toxic species (Benilova et al., 2012; Cohen et al., 2013;
Matsuzaki, 2014). The existence of mutants that lead to early onset AD (Wu et al., 2012) offers
an opportunity to characterize the conformational space available to the Aβ peptide in fibrillar or
oligomeric state. Amyloids in general, and Aβ in particular, are known for their ability to form
a number of polymorphs (Meier and Böckmann, 2015), and it has been proposed that they are
at the origin of different phenotypes of the disease, reminiscent of the appearance of strains in
prion disease (Meyer-Luehmann et al., 2006; Colby and Prusiner, 2011; Stöhr et al., 2012). Different
mutant forms of Aβ have been identified involving a single-residue deletion or substitution at or
adjacent to residue E22, e.g., Flemish A21G (Hendriks et al., 1992), Arctic E22G (Kamino et al.,
1992; Nilsberth et al., 2001), Dutch E22Q (Levy et al., 1990; Van Broeckhoven et al., 1990), Italian
E22K (Tagliavini et al., 1999; Bugiani et al., 2010), Iowa D23N (Grabowski et al., 2001), and the
Osaka deletion mutation E221 (Tomiyama et al., 2008; Ovchinnikova et al., 2011). These mutants
cause early-onset AD, and they display different toxicity profiles in in vitro and in vivo studies
compared to wild-type Aβ1-40 and Aβ1-42.
Knowledge of the atomic-resolution 3D structure is central for the understanding of the
molecular basis underlying the amyloid diseases, and solid-state NMR is a powerful method to
determine and characterize structures of amyloid fibrils at atomic resolution (Wasmer et al., 2008)
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FIGURE 1 | (A) Difference between the chemical shifts Cα, -Cβ and C’
between the Osaka mutant (Schütz et al., 2015) and wild-type Aβ 1-40,
Patient I of Lu et al. (2013). Cβ is given with negative values to highlight
differences in secondary structure propensity where all chemical-shift
differences point in the same direction; where the Osaka mutant shows
less β-strand structure, all three values are positive, and vice versa. The
chemical shifts are re-referenced to yield the smallest possible
differences. Even residues are shown in black, odd ones in cyan. (B)
Average absolute values of the mean chemical shift differences between
wild-type Aβ 1-40 (Lu et al., 2013) and the Osaka mutant (Schütz et al.,
2015),
(∣∣∣δCαWT − δCαOsaka
∣∣∣+
∣∣∣δCβWT − δCβOsaka
∣∣∣+∣∣∣δC′WT − δC′Osaka
∣∣∣
)/
3. Deviations larger than 1 ppm are plotted in red,
those smaller in blue. (C) Representation of chemical-shift differences
from (B) plotted on the Aβ1-40 E221 structure (pdb entry 2MVX). Same
color coding as in (B). Differences between Cα and Cβ secondary
chemical shifts for (D) wild-type Aβ 1-40 Patient I of Lu et al. (2013)
and (E) the Osaka mutant (Schütz et al., 2015). Arrows indicate
locations of β-sheets according to the rule that three negative values in
a row are indicative for this secondary structure element, with the
exception of glycines which are marked by a gray bar color.
and to map the conformational space available to these proteins.
In addition to the Osaka mutant structure, (Schütz et al., 2015)
several wild-type Aβ fibril polymorphs have been characterized
(Petkova et al., 2002; Paravastu et al., 2008; Bertini et al., 2011;
Lopez del Amo et al., 2012; Lu et al., 2013; Niu et al., 2014), and a
model for the Iowamutant was presented (Sgourakis et al., 2015).
Despite a large body of literature, there is presently not
enough high-resolution structural data available to establish a
detailed structure-toxicity relationship for amyloids in general,
and Aβ in particular (Tiller and Tessier, 2013). However, virtually
complete chemical-shift information for all 40 residues has
recently become available for two wild-type and a mutant form of
Aβ1-40. We use this information here to suggest, on the basis of
a comparison of NMR chemical-shift values between the Osaka
mutant (Huber et al., 2014; Schütz et al., 2015) and one of the
wild-type polymorphs (Lu et al., 2013), that the wild-type peptide
has indeed the ability to assume the fold established for Aβ1-40
E221 (Schütz et al., 2015), albeit with a modified in-out pattern
of the amino-acid residues in the loop comprising residues 20–
31. Furthermore, we illustrate how other early-onset Aβ mutants
can in principle form a similar fold. We speculate that the key
feature of the mutant folds is the formation of an intermolecular
salt bridge, attaching the N-terminal residues to the fibril core,
as opposed to the wild-type protein, where the situation is
substantially different, as residue K28 was experimentally shown
to be involved in an intramolecular salt bridge (Lu et al., 2013).
As a consequence, the N-terminus is less tightly attached, which
impacts fibril properties, and potentially those of prefibrillar
states (Tarus et al., 2006; Reddy et al., 2009).
Materials and Methods
Calculation of the Model for the WT Aβ Dimer
The calculation was performed as described for the “manual
calculations” in reference (Schütz et al., 2015). For residues 2–4,
and 20–31, TALOS+ angles were calculated from the deposited
chemical shifts (Lu et al., 2013). Unambiguous distance restraints,
as determined in Schütz et al. (2015) for the mutant form,
were used for the residues which show concomitant chemical
shifts in both proteins (blue residues in Figure 1C). The list of
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FIGURE 2 | (A) The structure of the Osaka mutant E221 from Schütz et al.
(2015); (B) speculative model of WT Aβ as described in the main text; and
hypothetical models of (C) Dutch mutant E22Q; (D) Iowa mutant D23N; (E)
Arctic mutant E22G; (F); Flemish mutant A21G; and (G) Italian mutant E22K.
(Continued)
FIGURE 2 | Continued
Models (C–G) are built based on the Osaka mutant structure and additional
considerations as described in the main text. All these mutants favor, in this
model, an outside orientation of K28. Hydrophobic residues are colored white,
glycines and polar residues are green, and charged residues are colored blue
when positive and red when negative.
distance restraints used is therefore a subset of the list given
in Schütz et al. (2015), namely the ones between two residues
from the range 1, 5–19, 32–40, and is listed in Table S1. The
orientations of the β-strands were defined for β-sheets 1, 2, 4,
and 5 in the same manner as in the mutant form (for the strand
numbering see Figures 1D–E). This input was not sufficient
to distinguish between the possible orientations of the two β-
strands spanning residues E22-V24 (strand 2a) and S26-K28
(strand 3) in the wild-type protein (Figure 1D) on the basis
of restraint violations. The following additional considerations
were used as constraints for the structure calculations: (i) The
assigned side-chain Cγ/δ chemical shifts in the brain-seeded
WT polymorph for D23 and E22 respectively show chemical-
shift values typical of charged COO− side-chain moieties (Lu
et al., 2013). (ii) The β-sheet structure of E22-V24 evidenced
by the secondary chemical shifts (Figure 1D) observed for the
brain-seeded WT polymorph implies that either E22 or D23
point to the inside of the fibril. (iii) The thus introduced E22
or D23 negative charge inside the fibril should be compensated
by a positive charge in order to yield a stable fibril. Here,
K28 is the only possible partner. From these three points, we
can infer that S26-K28 shows an in-out-in pattern, allowing
for charge compensation. This leaves the two options of an
out-in-out or in-out-in orientation for E22-V24, but steric
clashes between V24 and S26 (in an in-out-in orientation of
E22-V24) strongly suggest an out-in-out pattern, with D23
pointing inside. And indeed, the D23-K28 salt bridge has been
described in most WT models (Paravastu et al., 2006; Lu et al.,
2013).
Structural Models for the Mutants
For all mutant form models, dihedral angle restraints from
Schütz et al. (2015) were used and distance restraints from the
same source were entered into CYANA calculations, except
for residues 20–30 and 2–4. Hydrogen bonding patterns were
adopted from the Osaka mutant for the Arctic, Flemish and
Italian mutant. Like the WT model, the Dutch and Iowa mutant
calculations included an additional β-sheet 2a for residues 22–24
(see Figure 1D). Its orientation followed from two arguments:
(i) we avoid uncompensated charges inside the core of the fibril,
and (ii) we avoid steric clashes between residues V24 and S26. As
a result, the Iowa mutant has an out-in-out pattern (Figure 2D
and Figure S2C), as also predicted in a recent model for the
Iowa mutant (Sgourakis et al., 2015). While the Dutch mutant
assumes an in-out-in pattern for residues Q22-V24 (Figure 2C
and Figure S2B), the Arctic mutant shows an outside-pointing
D23 (Figure 2E and Figure S2D), and in the Flemish mutant
both E22 and D23 are oriented outwards and β-strand E22-V24
is not present (Figure 2F and Figure S2E). Finally, in the Italian
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TABLE 1 | Information used as input for WT model building.
Residues 5–19 and 32–40 Residues 1–4 and 20–31
Distance restraints Inter/Intra-molecularly and spectrally unambiguous restraints None
TALOS+ angles BMRB 25289 (Schütz et al., 2015) BMRB 19009 (Lu et al., 2013)
Sequence 1 10 20 30
DAEFRHDSG YEVHHQKLVF FAEDVGSNKG AIIGLMVGGVV
β-Strands
Orientation of first residue
1---- 2--------- 2a- 3-- 4-- 5--
In Out Out In Out In
Distance restraints from the Osaka mutant were used between the residues which show small chemical shift-differences (blue in Figure 1C). A list is given in Table S1. TALOS+ angles
were calculated from the given chemical shift depositions and the restraints for CYANA calculations had a range over the top 10 database matches ± 15◦. Residues without dihedral
angle restraints were: all glycines; residues D1 and V40 being the terminal residues; and residues A21 and V24 which had a warning in the TALOS+ prediction. Although F20 also has a
warning in the TALOS+ prediction, the restraint was still used, since secondary chemical shifts in both the WT (Lu et al., 2013) and the Osaka mutant (Schütz et al., 2015) convincingly
indicate that the β-strand that starts from Y10 ends at F19. F20 thus should discontinue the strand and have the same orientation as F19. β-strands were established according to
Figure 3 and Figure S8 in Schütz et al. (2015). Strand 2a does not exist in the Osaka mutant, but is suggested in the WT form by the chemical shifts (Lu et al., 2013) (Figure 1D). The
orientation of the side chains is defined by the hydrogen bonding pattern between the different layers of the fibril and the resultant orientation of the first residue in each strand is given
as inward or outward with respect to the core of the dimer.
mutant (Figure 2G and Figure S2F), we force the formation of a
K22-D23 salt bridge by adding a restraint to the CYANA where
no electrostatic interactions are considered. Without restraint
violations, this residue pair can only be accommodated outside
the loop due to limited space on the inside. The structural
statistics for all mutant calculations as well as the wildtype is
given in Table S2.
Results and Discussion
The Wild-Type Protein Can Adopt a Similar Fold
as the Osaka Mutant
Chemical-shift comparisons between proteins represent
a sensitive means to assess differences and similarities in
3D structures, as shift differences point to conformational
differences for the observed residue. Comparison of wild-type
Aβ chemical shifts described by Lu et al. (2013) to those of the
Aβ1-40 E221 mutant (Schütz et al., 2015) (Figure 1A) reveals
that the two forms display almost coincident shifts for large parts
of the protein, with noticeable exceptions in two regions where
the differences surpass the 1 ppm limit which we consider to be
a significant change.
To illustrate the location of these changes, we plotted the
absolute value of the mean chemical-shift differences from
Figure 1A, displayed in Figure 1B, on the Aβ E221 mutant
structure in Figure 1C: residues with similar shifts are colored in
blue, others in red. Blue residues cover the entire hydrophobic
core, as well as the largest parts of β-sheets 1 and 2. Importantly,
the two regions displaying larger chemical-shift differences
are distant in sequence, but spatially contiguous if plotted on
the Aβ E221 mutant structure. They concern the loop as well
as the N-terminus attached to the loop via the E3-K28 salt
bridge. For comparison, the other wild-type polymorph with
complete assignments (Bertini et al., 2011) shows substantial
chemical-shift differences spanning the entire sequence, with
only few and possibly fortuitous exceptions (see Supplementary
Figures S1A–C).
Comparison of Secondary Structural Features of
WT Aβ and the Osaka Mutant
Secondary chemical shifts [the difference to random-coil shifts
(Bax, 1991; Wishart and Sykes, 1994)] inform on protein
secondary structures. The secondary shift differences 1δCα-
1δCβ can be evaluated according to a pattern of three
consecutive negative values corresponding to a β-strand, four
positive values in a row indicating α-helical secondary structure,
and the remainder turns or loops. 1δCα-1δCβ of Aβ1-40 and
Aβ1-40 E221 is plotted in Figures 1D,E and the resulting pattern
of β-sheets is found to be quite similar, with a couple of noticeable
differences: for residues A2 and G3, where the mutant protein
structure presents a turn, theWT protein chemical shifts indicate
a straight β-strand, extending the strand which in Aβ1-40 E221
spans residues F4 to S8. The turn comprising residues F20-V24
in the mutant form is reduced, in the WT peptide, to residues
F20-A21, and an additional β-strand, E22-V24 is present. We
note from Figure 1 that the β-sheet S26-K28 is conserved, but
that the individual chemical shifts (Figure 1A) differ significantly
(>1 ppm). Residues F4–F19 and residues I30-V40 feature very
similar shifts for the WT and the Osaka-mutant fibril.
A Speculative Structure for a WT Aβ Polymorph
We have noted that the monomer conformation for the
residues mentioned above is very similar for the WT from
the brain-seeded sample and the Osaka mutation despite the
fact that the polymorph of the mutant form is described
by a two-fold symmetry (Schütz et al., 2015) and the WT
polymorph by a three-fold symmetry (Lu et al., 2013). In the
following, we construct a two-fold model of a monomer in
a WT fibril using the information provided in Table 1. The
model mainly relies on the data coming from the mutant
form, complemented by information from the brain seeded
WT form for the residues showing chemical shift differences
between the two forms. Details are given in the Materials and
Methods Section. The corresponding calculation resulted in no
restraint violations, and the atomic-detail model is displayed
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for information in Figure S2. Figure 2B represents the region
of interest as a schematic drawing, in order to emphasize its
nature as a speculative model. When compared to the Osaka
mutant structure shown in Figure 2A, the two β-sheets E22-V24
and S26-K28 in this model are turned around (inside/outside
interchanged) to accommodate the K28-D23 salt bridge inside
the loop (see Materials and Methods Section). The attachment
of β-sheet 1 (Figure 1C) is now only mediated by the H6-
E11-E13-V40 salt bridge network (Schütz et al., 2015), as
well as F4-A30 hydrophobic interactions, and lacks the strong
electrostatic stabilization by E3-K28. This would explain the
dynamic nature of the N-terminal part, roughly 10 residues,
which has systematically been observed in the WT forms. These
residues were shown to display a certain flexibility (allowing for
H/D exchange or giving raise to weak or missing signals in solid-
state NMR spectra) in most polymorphs described, and could
only be sequentially assigned for Aβ1-40 E221 and three wild-
type models (Bertini et al., 2011; Lu et al., 2013; Niu et al.,
2014). Even in these, no unambiguous distance restraints could
be established between the N-terminal segment and the fibril
core. Only the Aβ1-40 E221 mutant distinguishes itself by a
rigid N-terminal segment, structurally unambiguously defined
by the intermolecular E3-K28 salt bridge. We speculate that
this stabilizing salt bridge is a direct consequence of the E221
mutation, and we illustrate in the following how it might
occur as well in other early-onset AD related Aβ variants,
where mutations are found in the in the loop around residue
A21-D23.
Structural Models for Other Mutant Forms
A common feature shared by all the here discussed early-onset
mutants is that their amino-acids composition is such that the
presence of a negative charge in the fibril interior can be avoided,
which in turn allows an outside orientation of Lys28 and a
rigidification of the N-terminal β-strand by its attachment to the
fibril core via the E3-K28 salt bridge. Hypothetical models for
the different mutant forms are shown in Figure S2 (for details
of the calculations, see Materials and Methods Section), and
drawings of the regions of interest are shown in Figures 2C–G.
The Dutch, Iowa and Arctic mutants all result in the replacement
of a negative charge of the wild-type peptide, either D23 or E22,
by a polar residue, which easily accommodates then a charge-
free fibril interior in the loop encompassing residues 20–31.
In the Flemishmutant, the A21Gmutation introduced additional
flexibility, which can accommodate an outside orientation of
both E22 and D23. In the Italian mutant, replacement of E22
by a positive charge (K22) allows to stabilize D23 outside by a
salt bridge with K22. The calculations carried out for the mutant
forms (Figure S2) show that the above discussed hypothetical
conformations can be realized without steric hindrance.
Conclusion
In summary, while we cannot ascertain from our calculations
that Lys28 must be pointing outside in the early onset Aβ
mutants discussed here, we could show that there are no restraint
violations, static clashes or unbalanced charges inside the loop
when Lys28 points outside. Consequently, the residue can engage
in an energetically favorable salt bridge with the N-terminus
of the protein. The Osaka polymorph fold is thus in principle
accessible to the other mutant forms, and the possibility to
assume this fold could be of importance to early onset. In
any case, the models presented here provide presently testable
hypotheses in mutational studies allowing to experimentally
confirm the central role of K28 in the increased toxicity of mutant
forms (Levy et al., 1990; Van Broeckhoven et al., 1990; Hendriks
et al., 1992; Tagliavini et al., 1999; Grabowski et al., 2001;
Nilsberth et al., 2001; Tomiyama et al., 2008; Bugiani et al., 2010).
More chemical-shift information and high-resolution structures
of different polymorphs of WT Aβ and mutant fibrils of both
Aβ1-40 and 1-42 and, hopefully, oligomers (Stroud et al., 2012),
will be needed to reliably establish a clear relationship between
structure and biological activity of the protein.
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